nodes	percent_of_prediction	percent_of_DWPC	metapath
Enalapril—ABCB1—Parkinson's disease	0.795	1	CbGaD
Enalapril—ACE—forelimb zeugopod—Parkinson's disease	0.0255	0.171	CbGeAlD
Enalapril—ACE—sympathetic nervous system—Parkinson's disease	0.0185	0.124	CbGeAlD
Enalapril—ACE—forelimb—Parkinson's disease	0.0128	0.0859	CbGeAlD
Enalapril—ACE—autonomic nervous system—Parkinson's disease	0.0125	0.0835	CbGeAlD
Enalapril—ACE—arm—Parkinson's disease	0.011	0.0738	CbGeAlD
Enalapril—ACE—peripheral nervous system—Parkinson's disease	0.00899	0.0603	CbGeAlD
Enalapril—ACE—nerve—Parkinson's disease	0.00701	0.047	CbGeAlD
Enalapril—ACE—Metabolism of Angiotensinogen to Angiotensins—ATP6AP2—Parkinson's disease	0.00533	0.12	CbGpPWpGaD
Enalapril—ACE—ACE Inhibitor Pathway—ATP6AP2—Parkinson's disease	0.00508	0.115	CbGpPWpGaD
Enalapril—ACE—embryo—Parkinson's disease	0.00328	0.022	CbGeAlD
Enalapril—SLCO1A2—forebrain—Parkinson's disease	0.00305	0.0205	CbGeAlD
Enalapril—ACE—forebrain—Parkinson's disease	0.0029	0.0195	CbGeAlD
Enalapril—Benazepril—MTHFR—Parkinson's disease	0.00274	0.251	CrCbGaD
Enalapril—Captopril—CYP2D6—Parkinson's disease	0.00253	0.232	CrCbGaD
Enalapril—ACE—cardiovascular system—Parkinson's disease	0.00246	0.0165	CbGeAlD
Enalapril—SLCO1A2—medulla oblongata—Parkinson's disease	0.0022	0.0148	CbGeAlD
Enalapril—SLC22A7—brain—Parkinson's disease	0.00209	0.014	CbGeAlD
Enalapril—SLC22A6—brain—Parkinson's disease	0.00202	0.0135	CbGeAlD
Enalapril—SLCO1A2—midbrain—Parkinson's disease	0.00201	0.0135	CbGeAlD
Enalapril—SLCO1A2—spinal cord—Parkinson's disease	0.00197	0.0132	CbGeAlD
Enalapril—CYP3A4—Felbamate Metabolism—CYP2E1—Parkinson's disease	0.00188	0.0425	CbGpPWpGaD
Enalapril—ACE—spinal cord—Parkinson's disease	0.00187	0.0125	CbGeAlD
Enalapril—Captopril—ABCB1—Parkinson's disease	0.00181	0.165	CrCbGaD
Enalapril—SLCO1A2—head—Parkinson's disease	0.00175	0.0117	CbGeAlD
Enalapril—SLC22A8—head—Parkinson's disease	0.00167	0.0112	CbGeAlD
Enalapril—ACE—head—Parkinson's disease	0.00166	0.0111	CbGeAlD
Enalapril—SLCO1A2—nervous system—Parkinson's disease	0.00166	0.0111	CbGeAlD
Enalapril—SLCO1A2—central nervous system—Parkinson's disease	0.00159	0.0107	CbGeAlD
Enalapril—SLC22A8—nervous system—Parkinson's disease	0.00158	0.0106	CbGeAlD
Enalapril—ACE—nervous system—Parkinson's disease	0.00158	0.0106	CbGeAlD
Enalapril—SLCO1A2—cerebellum—Parkinson's disease	0.00156	0.0104	CbGeAlD
Enalapril—SLC22A8—central nervous system—Parkinson's disease	0.00152	0.0102	CbGeAlD
Enalapril—ACE—central nervous system—Parkinson's disease	0.00152	0.0102	CbGeAlD
Enalapril—ACE—Peptide hormone metabolism—ATP6AP2—Parkinson's disease	0.0014	0.0316	CbGpPWpGaD
Enalapril—SLCO1A2—brain—Parkinson's disease	0.00127	0.00849	CbGeAlD
Enalapril—SLC22A8—brain—Parkinson's disease	0.00121	0.0081	CbGeAlD
Enalapril—ACE—brain—Parkinson's disease	0.0012	0.00808	CbGeAlD
Enalapril—ABCB1—embryo—Parkinson's disease	0.00116	0.00775	CbGeAlD
Enalapril—Perindopril—ABCB1—Parkinson's disease	0.00114	0.104	CrCbGaD
Enalapril—ABCB1—Codeine and Morphine Metabolism—CYP2D6—Parkinson's disease	0.0011	0.0249	CbGpPWpGaD
Enalapril—ABCB1—forebrain—Parkinson's disease	0.00102	0.00685	CbGeAlD
Enalapril—Lisinopril—ABCB1—Parkinson's disease	0.001	0.0918	CrCbGaD
Enalapril—Cilazapril—ABCB1—Parkinson's disease	0.001	0.0918	CrCbGaD
Enalapril—ABCB1—cardiovascular system—Parkinson's disease	0.000864	0.00579	CbGeAlD
Enalapril—CYP3A4—nervous system—Parkinson's disease	0.000784	0.00525	CbGeAlD
Enalapril—CYP3A4—central nervous system—Parkinson's disease	0.000755	0.00506	CbGeAlD
Enalapril—ABCB1—medulla oblongata—Parkinson's disease	0.000739	0.00495	CbGeAlD
Enalapril—Nateglinide—CYP2D6—Parkinson's disease	0.000704	0.0644	CrCbGaD
Enalapril—SLC22A7—Fluoropyrimidine Activity—MTHFR—Parkinson's disease	0.00068	0.0153	CbGpPWpGaD
Enalapril—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—Parkinson's disease	0.000679	0.0153	CbGpPWpGaD
Enalapril—ABCB1—midbrain—Parkinson's disease	0.000675	0.00452	CbGeAlD
Enalapril—ABCB1—spinal cord—Parkinson's disease	0.000659	0.00441	CbGeAlD
Enalapril—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC18A2—Parkinson's disease	0.000637	0.0144	CbGpPWpGaD
Enalapril—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—Parkinson's disease	0.000586	0.0132	CbGpPWpGaD
Enalapril—ABCB1—head—Parkinson's disease	0.000585	0.00392	CbGeAlD
Enalapril—ABCB1—nervous system—Parkinson's disease	0.000555	0.00372	CbGeAlD
Enalapril—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC18A2—Parkinson's disease	0.000535	0.0121	CbGpPWpGaD
Enalapril—ABCB1—central nervous system—Parkinson's disease	0.000534	0.00358	CbGeAlD
Enalapril—CYP3A4—Aflatoxin B1 metabolism—GSTM1—Parkinson's disease	0.000524	0.0118	CbGpPWpGaD
Enalapril—ABCB1—cerebellum—Parkinson's disease	0.000522	0.0035	CbGeAlD
Enalapril—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—Parkinson's disease	0.000493	0.0111	CbGpPWpGaD
Enalapril—CYP3A4—Codeine and Morphine Metabolism—ABCB1—Parkinson's disease	0.000485	0.0109	CbGpPWpGaD
Enalapril—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC18A2—Parkinson's disease	0.000447	0.0101	CbGpPWpGaD
Enalapril—ABCB1—brain—Parkinson's disease	0.000424	0.00284	CbGeAlD
Enalapril—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Parkinson's disease	0.000418	0.00943	CbGpPWpGaD
Enalapril—ACE—Peptide hormone metabolism—INS—Parkinson's disease	0.000414	0.00934	CbGpPWpGaD
Enalapril—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—Parkinson's disease	0.000411	0.00928	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—HSPA9—Parkinson's disease	0.000392	0.00885	CbGpPWpGaD
Enalapril—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—Parkinson's disease	0.00039	0.0088	CbGpPWpGaD
Enalapril—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.000357	0.00805	CbGpPWpGaD
Enalapril—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Parkinson's disease	0.000351	0.00792	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—LRRK2—Parkinson's disease	0.000342	0.00773	CbGpPWpGaD
Enalapril—CYP3A4—Xenobiotics—CYP2D6—Parkinson's disease	0.000326	0.00736	CbGpPWpGaD
Enalapril—CYP3A4—Estrogen metabolism—NQO1—Parkinson's disease	0.000321	0.00724	CbGpPWpGaD
Enalapril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.000317	0.00715	CbGpPWpGaD
Enalapril—CYP3A4—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.000314	0.00708	CbGpPWpGaD
Enalapril—CYP3A4—Xenobiotics—CYP2E1—Parkinson's disease	0.000298	0.00673	CbGpPWpGaD
Enalapril—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Parkinson's disease	0.000293	0.00661	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—GDNF—Parkinson's disease	0.000291	0.00657	CbGpPWpGaD
Enalapril—SLC22A7—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	0.000289	0.00653	CbGpPWpGaD
Enalapril—CYP3A4—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.000287	0.00648	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—RPL6—Parkinson's disease	0.000279	0.0063	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000277	0.00625	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000277	0.00625	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—VIM—Parkinson's disease	0.000274	0.00618	CbGpPWpGaD
Enalapril—SLC15A1—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	0.000273	0.00617	CbGpPWpGaD
Enalapril—CYP3A4—Estrogen metabolism—COMT—Parkinson's disease	0.000269	0.00607	CbGpPWpGaD
Enalapril—CYP3A4—Tryptophan metabolism—DDC—Parkinson's disease	0.000268	0.00604	CbGpPWpGaD
Enalapril—SLC22A7—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.000266	0.00601	CbGpPWpGaD
Enalapril—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—Parkinson's disease	0.000265	0.00599	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—ATP6AP2—Parkinson's disease	0.000265	0.00598	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000262	0.00591	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000262	0.00591	CbGpPWpGaD
Enalapril—ABCB1—HIF-1-alpha transcription factor network—CP—Parkinson's disease	0.000255	0.00575	CbGpPWpGaD
Enalapril—SLC15A1—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.000252	0.00568	CbGpPWpGaD
Enalapril—CYP3A4—Estrogen metabolism—GSTM1—Parkinson's disease	0.000246	0.00555	CbGpPWpGaD
Enalapril—SLC22A8—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	0.000243	0.00549	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—HLA-DRA—Parkinson's disease	0.000242	0.00547	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—DCTN1—Parkinson's disease	0.000242	0.00547	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000233	0.00526	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000233	0.00526	CbGpPWpGaD
Enalapril—CYP3A4—Tryptophan metabolism—MAOB—Parkinson's disease	0.000225	0.00509	CbGpPWpGaD
Enalapril—SLC22A8—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.000224	0.00505	CbGpPWpGaD
Enalapril—SLCO1A2—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	0.000216	0.00487	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—RPL23A—Parkinson's disease	0.000212	0.00478	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—RPL14—Parkinson's disease	0.000212	0.00478	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000207	0.00467	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000207	0.00467	CbGpPWpGaD
Enalapril—SLC22A6—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	0.000203	0.00458	CbGpPWpGaD
Enalapril—SLCO1A2—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.000199	0.00449	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—RPS8—Parkinson's disease	0.000197	0.00446	CbGpPWpGaD
Enalapril—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.000195	0.0044	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000194	0.00439	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000194	0.00439	CbGpPWpGaD
Enalapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—Parkinson's disease	0.000191	0.0043	CbGpPWpGaD
Enalapril—SLC22A7—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.00019	0.00428	CbGpPWpGaD
Enalapril—SLC22A6—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.000187	0.00422	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000185	0.00417	CbGpPWpGaD
Enalapril—SLC15A1—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.000179	0.00405	CbGpPWpGaD
Enalapril—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.00016	0.00361	CbGpPWpGaD
Enalapril—SLC22A8—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.000159	0.0036	CbGpPWpGaD
Enalapril—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.000153	0.00346	CbGpPWpGaD
Enalapril—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.000152	0.00344	CbGpPWpGaD
Enalapril—ABCB1—HIF-1-alpha transcription factor network—HMOX1—Parkinson's disease	0.000152	0.00342	CbGpPWpGaD
Enalapril—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000148	0.00333	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000147	0.00332	CbGpPWpGaD
Enalapril—ABCB1—HIF-1-alpha transcription factor network—EDN1—Parkinson's disease	0.000143	0.00322	CbGpPWpGaD
Enalapril—SLCO1A2—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.000142	0.0032	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000139	0.00314	CbGpPWpGaD
Enalapril—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000135	0.00306	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000135	0.00305	CbGpPWpGaD
Enalapril—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000134	0.00302	CbGpPWpGaD
Enalapril—SLC22A6—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.000133	0.003	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—MAP3K5—Parkinson's disease	0.000128	0.00289	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000128	0.00289	CbGpPWpGaD
Enalapril—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000124	0.0028	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000124	0.00279	CbGpPWpGaD
Enalapril—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000122	0.00276	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—IGF2—Parkinson's disease	0.000118	0.00266	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000115	0.0026	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000114	0.00257	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—FASLG—Parkinson's disease	0.000114	0.00257	CbGpPWpGaD
Enalapril—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.00011	0.00248	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.00011	0.00248	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—ND3—Parkinson's disease	0.000109	0.00245	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—MCCC1—Parkinson's disease	0.000109	0.00245	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—Parkinson's disease	0.000106	0.0024	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000103	0.00233	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—OMD—Parkinson's disease	0.000102	0.00231	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—TALDO1—Parkinson's disease	0.000102	0.00231	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000101	0.00228	CbGpPWpGaD
Enalapril—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.0001	0.00227	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—NDUFB11—Parkinson's disease	9.68e-05	0.00219	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	9.64e-05	0.00218	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—CP—Parkinson's disease	9.49e-05	0.00214	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—CYCS—Parkinson's disease	9.26e-05	0.00209	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—GCH1—Parkinson's disease	9.24e-05	0.00209	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	9.11e-05	0.00206	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	8.85e-05	0.002	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	8.85e-05	0.002	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	8.8e-05	0.00199	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	8.75e-05	0.00197	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	8.68e-05	0.00196	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	8.33e-05	0.00188	CbGpPWpGaD
Enalapril—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	8.26e-05	0.00186	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—FBP1—Parkinson's disease	8.23e-05	0.00186	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—DBH—Parkinson's disease	8.23e-05	0.00186	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—GBA—Parkinson's disease	8.23e-05	0.00186	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	8.1e-05	0.00183	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	8.05e-05	0.00182	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	7.85e-05	0.00177	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—INS—Parkinson's disease	7.81e-05	0.00176	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—CYCS—Parkinson's disease	7.78e-05	0.00176	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	7.72e-05	0.00174	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	7.6e-05	0.00172	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	7.3e-05	0.00165	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	7.2e-05	0.00162	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	6.91e-05	0.00156	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	6.76e-05	0.00153	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	6.76e-05	0.00153	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—CYCS—Parkinson's disease	6.49e-05	0.00147	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	6.49e-05	0.00147	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	6.42e-05	0.00145	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—IL1B—Parkinson's disease	6.41e-05	0.00145	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—CASP3—Parkinson's disease	6.4e-05	0.00144	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	6.32e-05	0.00143	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—DDC—Parkinson's disease	6.04e-05	0.00136	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	6.01e-05	0.00136	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	5.83e-05	0.00132	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	5.76e-05	0.0013	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	5.75e-05	0.0013	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—GSTA4—Parkinson's disease	5.71e-05	0.00129	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	5.64e-05	0.00127	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	5.64e-05	0.00127	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	5.61e-05	0.00127	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	5.42e-05	0.00122	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	5.33e-05	0.0012	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	5.26e-05	0.00119	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PLA2G6—Parkinson's disease	5.14e-05	0.00116	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—MAOB—Parkinson's disease	5.09e-05	0.00115	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	4.84e-05	0.00109	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	4.7e-05	0.00106	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—TNF—Parkinson's disease	4.65e-05	0.00105	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—MCCC1—Parkinson's disease	4.65e-05	0.00105	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—ND3—Parkinson's disease	4.65e-05	0.00105	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—COMT—Parkinson's disease	4.42e-05	0.000998	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	4.4e-05	0.000993	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	4.39e-05	0.000991	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—TALDO1—Parkinson's disease	4.37e-05	0.000987	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—OMD—Parkinson's disease	4.37e-05	0.000987	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	4.36e-05	0.000984	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	4.34e-05	0.000979	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—CP—Parkinson's disease	4.32e-05	0.000976	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—NDUFB11—Parkinson's disease	4.15e-05	0.000936	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	4.04e-05	0.000912	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	3.99e-05	0.0009	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GCH1—Parkinson's disease	3.96e-05	0.000893	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—CYP2D6—Parkinson's disease	3.78e-05	0.000853	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—CTGF—Parkinson's disease	3.71e-05	0.000838	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GBA—Parkinson's disease	3.53e-05	0.000796	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—FBP1—Parkinson's disease	3.53e-05	0.000796	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—DBH—Parkinson's disease	3.53e-05	0.000796	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—CYP2E1—Parkinson's disease	3.46e-05	0.000781	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—NQO1—Parkinson's disease	3.42e-05	0.000772	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—TH—Parkinson's disease	3.37e-05	0.000761	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—CYCS—Parkinson's disease	3.24e-05	0.00073	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	3.16e-05	0.000713	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	3.08e-05	0.000695	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	2.96e-05	0.000668	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	2.9e-05	0.000655	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—MCCC1—Parkinson's disease	2.87e-05	0.000647	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—ND3—Parkinson's disease	2.87e-05	0.000647	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—COMT—Parkinson's disease	2.87e-05	0.000647	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—GSTP1—Parkinson's disease	2.85e-05	0.000644	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—MAOA—Parkinson's disease	2.85e-05	0.000642	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—HMOX1—Parkinson's disease	2.81e-05	0.000635	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—ABCB1—Parkinson's disease	2.7e-05	0.000609	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—TALDO1—Parkinson's disease	2.69e-05	0.000608	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—OMD—Parkinson's disease	2.69e-05	0.000608	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—GSTM1—Parkinson's disease	2.62e-05	0.000592	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—DDC—Parkinson's disease	2.59e-05	0.000584	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	2.57e-05	0.00058	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	2.55e-05	0.000577	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—GPX1—Parkinson's disease	2.51e-05	0.000567	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GSTA4—Parkinson's disease	2.44e-05	0.000552	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GCH1—Parkinson's disease	2.44e-05	0.00055	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—MTHFR—Parkinson's disease	2.32e-05	0.000523	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	2.3e-05	0.000518	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PLA2G6—Parkinson's disease	2.2e-05	0.000497	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—MAOB—Parkinson's disease	2.18e-05	0.000492	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GBA—Parkinson's disease	2.17e-05	0.00049	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—FBP1—Parkinson's disease	2.17e-05	0.00049	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—DBH—Parkinson's disease	2.17e-05	0.00049	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—APOE—Parkinson's disease	2.16e-05	0.000487	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—INS—Parkinson's disease	1.84e-05	0.000416	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CYP2D6—Parkinson's disease	1.62e-05	0.000365	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—DDC—Parkinson's disease	1.59e-05	0.00036	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CTGF—Parkinson's disease	1.59e-05	0.000359	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GSTA4—Parkinson's disease	1.51e-05	0.00034	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CYP2E1—Parkinson's disease	1.48e-05	0.000334	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—NQO1—Parkinson's disease	1.46e-05	0.00033	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—TH—Parkinson's disease	1.44e-05	0.000326	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CYCS—Parkinson's disease	1.39e-05	0.000313	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	1.36e-05	0.000306	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—MAOB—Parkinson's disease	1.34e-05	0.000303	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—COMT—Parkinson's disease	1.23e-05	0.000277	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GSTP1—Parkinson's disease	1.22e-05	0.000276	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—MAOA—Parkinson's disease	1.22e-05	0.000275	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—HMOX1—Parkinson's disease	1.2e-05	0.000272	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GSTM1—Parkinson's disease	1.12e-05	0.000253	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GPX1—Parkinson's disease	1.07e-05	0.000243	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	9.97e-06	0.000225	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—MTHFR—Parkinson's disease	9.92e-06	0.000224	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CTGF—Parkinson's disease	9.79e-06	0.000221	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—APOE—Parkinson's disease	9.23e-06	0.000208	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	9.12e-06	0.000206	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—NQO1—Parkinson's disease	9.02e-06	0.000204	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—TH—Parkinson's disease	8.89e-06	0.000201	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CYCS—Parkinson's disease	8.53e-06	0.000193	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—INS—Parkinson's disease	7.89e-06	0.000178	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—COMT—Parkinson's disease	7.56e-06	0.000171	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GSTP1—Parkinson's disease	7.52e-06	0.00017	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—MAOA—Parkinson's disease	7.5e-06	0.000169	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—HMOX1—Parkinson's disease	7.42e-06	0.000167	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—ABCB1—Parkinson's disease	7.12e-06	0.000161	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GSTM1—Parkinson's disease	6.91e-06	0.000156	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GPX1—Parkinson's disease	6.62e-06	0.000149	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—MTHFR—Parkinson's disease	6.11e-06	0.000138	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—APOE—Parkinson's disease	5.69e-06	0.000128	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—INS—Parkinson's disease	4.86e-06	0.00011	CbGpPWpGaD
